신풍제약우
14,150KRWMarket close of 10/20 (Tue)
Down -1.05%-150KRWMarket close of 10/20 (Tue)
- Open
- 14,390
- High
- 14,390
- Low
- 13,970
- Day range
- Day range low 13,970 high 14,390, open 14,390, close 14,150, previous close 14,300
- Volume
- 0×10K shares
- 15.97 million KRW 0.29× the 20-session average
Market close of 10/20 (Tue)
Where it sits in the 1-year range
20%1-year close range 10,690 to 28,100 won, 20% up from the low
20% of the way up from the lowest close in 1 year (252 sessions) · -49.6% from the high
Usual range
Nothing unusual in the 4 checked items
Free · no sign-inSource from 2021-05-17
Points to check
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
- Daily moveusual range-1.05%-1.05%, 0.5× the usual (20-session average ±2.17%)That day -1.05% · usual ±2.17% · large-move threshold ±4.3%
The other 3 are within the usual range
- Trading value0.3×usual range
- EarningsOperating income, 8 quarters
- Data date10/20 (Tue)Market close
See the full check report
Quarterly results · Q1 2026
- Revenue54.5B KRW
- vs. year ago
- -1.6%
- vs. prior quarter
- -6.1%
- Operating income-363.22 million KRW
- vs. year ago
- Still a loss
- vs. prior quarter
- Turned to loss
- Operating margin-0.7%
- vs. year ago
- +2.5 pp
- vs. prior quarter
- -7.3 pp
Quarterly operating income trend
Same sector · 제약
Down -1.68%· 29 of 168 stocks up, preferred shares excluded · trading value 827.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 셀트리온 | Close over the last 20 sessions +11.4% | Down -0.40% | 139.2B KRW |
| 삼성바이오로직스 | Close over the last 20 sessions -1.3% | Down -2.52% | 129.9B KRW |
| 삼익제약 | Close over the last 20 sessions -20.4% | Up +2.77% | 76.0B KRW |
| 녹십자엠에스 | Close over the last 20 sessions +30.5% | Up +6.67% | 55.6B KRW |
| 유한양행 | Close over the last 20 sessions +11.5% | Down -1.37% | 41.6B KRW |
Other share classes of this company · 신풍제약
Schedule
- Next data 10/22 (Thu) after 08:50
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 81% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.